Plat-E: an efficient and stable system for transient packaging of retroviruses - PubMed (original) (raw)
Plat-E: an efficient and stable system for transient packaging of retroviruses
S Morita et al. Gene Ther. 2000 Jun.
Abstract
A potent retrovirus packaging cell line named Platinum-E (Plat-E) was generated based on the 293T cell line. Plat-E is superior to existing packaging cell lines regarding efficiency, stability and safety. The novel packaging constructs utilized in establishment of Plat-E ensure high and stable expression of viral structural proteins. Conventional packaging constructs made use of the promoter of MuLV-LTR for expression of viral structural genes gag-pol and env, while our packaging constructs utilized the EF1alpha promoter, which is 100-fold more potent than the MuLV-LTR in 293T cells in combination with the Kozak's consensus sequence upstream of the initiation codon resulting in high expression of virus structural proteins in Plat-E cells. To maintain the high titers of retroviruses under drug selection pressure, we inserted the IRES (internal ribosome entry site) sequence between the gene encoding gag-pol or env, and the gene encoding a selectable marker in the packaging constructs. Plat-E cells can stably produce retroviruses with an average titer of 1 x 107/ml for at least 4 months. In addition, as we used only the coding sequences of viral structural genes to avoid inclusion of unnecessary retrovirus sequences in the packaging constructs, the probability of generating the replication competent retroviruses (RCR) by recombination can virtually be ruled out.
Similar articles
- Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568 - Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG, Goff SP, Bank A. Markowitz DG, et al. Trans Assoc Am Physicians. 1988;101:212-8. Trans Assoc Am Physicians. 1988. PMID: 3077729 - Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS, Han E, Hong Y, Lee JT, Kim S, Kim S. Yu SS, et al. Gene Ther. 2003 Apr;10(8):706-11. doi: 10.1038/sj.gt.3301892. Gene Ther. 2003. PMID: 12692599 - Safety considerations in vector development.
Kappes JC, Wu X. Kappes JC, et al. Somat Cell Mol Genet. 2001 Nov;26(1-6):147-58. doi: 10.1023/a:1021082815013. Somat Cell Mol Genet. 2001. PMID: 12465466 Review. - Gene therapy in the central nervous system: the use of recombinant retroviruses.
Suhr ST, Gage FH. Suhr ST, et al. Arch Neurol. 1999 Mar;56(3):287-92. doi: 10.1001/archneur.56.3.287. Arch Neurol. 1999. PMID: 10190818 Review.
Cited by
- NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation.
Shimosato Y, Yamamoto K, Jia Y, Zhang W, Shiba N, Hayashi Y, Ito S, Kitamura T, Goyama S. Shimosato Y, et al. Leukemia. 2024 Oct 23. doi: 10.1038/s41375-024-02438-w. Online ahead of print. Leukemia. 2024. PMID: 39443736 - Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AML.
Nogami A, Amemiya HJ, Fujiwara H, Umezawa Y, Tohda S, Nagao T. Nogami A, et al. Int J Mol Sci. 2024 Sep 26;25(19):10372. doi: 10.3390/ijms251910372. Int J Mol Sci. 2024. PMID: 39408703 Free PMC article. - An Enhanced Retroviral Vector for Efficient Genetic Manipulation and Selection in Mammalian Cells.
Triller J, Prots I, Jäck HM, Wittmann J. Triller J, et al. Biomolecules. 2024 Sep 6;14(9):1131. doi: 10.3390/biom14091131. Biomolecules. 2024. PMID: 39334897 Free PMC article. - HDAC7 is a potential therapeutic target in acute erythroid leukemia.
Zhang W, Yamamoto K, Chang YH, Yabushita T, Hao Y, Shimura R, Nakahara J, Shikata S, Iida K, Chen Q, Zhang X, Kitamura T, Goyama S. Zhang W, et al. Leukemia. 2024 Sep 15. doi: 10.1038/s41375-024-02394-5. Online ahead of print. Leukemia. 2024. PMID: 39277669 - Knockout of the orphan membrane transporter Slc22a23 leads to a lean and hyperactive phenotype with a small hippocampal volume.
Uchimura Y, Hino K, Hattori K, Kubo Y, Owada A, Kimura T, Sugawara L, Kume S, Bellier JP, Yanagisawa D, Shiino A, Nakayama T, Daigo Y, Mashimo T, Udagawa J. Uchimura Y, et al. PLoS One. 2024 Aug 28;19(8):e0309461. doi: 10.1371/journal.pone.0309461. eCollection 2024. PLoS One. 2024. PMID: 39197039 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous